The global biosimilar market was valued at USD 26.5 billion in 2024. According to IMARC Group, the market is projected to reach USD 185.1 billion by 2033, growing at a CAGR of 24.1% from 2025 to 2033. Europe currently leads the market. Key factors driving growth include the expiration of patents for major biologic drugs, increasing awareness of the efficacy and cost benefits of biosim... https://www.imarcgroup.com/biosimilar-market